116 related articles for article (PubMed ID: 36424255)
1. Patient-specific biokinetics and hybrid 2D/3D approach integration in OEDIPE software: Application to radioiodine therapy.
Bensiali M; Anizan N; Leboulleux S; Lamart S; Davesne E; Broggio D; Desbrée A; Franck D
Phys Med; 2023 Sep; 113():102462. PubMed ID: 36424255
[TBL] [Abstract][Full Text] [Related]
2. A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods.
Belli ML; Mezzenga E; Di Iorio V; Celli M; Caroli P; Canali E; Matteucci F; Tardelli E; Grassi I; Sansovini M; Nicolini S; Severi S; Cremonesi M; Ferrari M; Paganelli G; Sarnelli A
J Vis Exp; 2020 Apr; (158):. PubMed ID: 32391816
[TBL] [Abstract][Full Text] [Related]
3. Simplified image-based dosimetry using planar images and patient-specific S-values.
Kim KM; Suh M; Cheon GJ; Lee MS; Lee JS
Med Phys; 2024 Feb; ():. PubMed ID: 38340367
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry estimation and preliminary clinical application of [
Yang H; Gao Z; Xu X; Liu C; Hu S; Zhang J; Song S
Ann Nucl Med; 2023 Jan; 37(1):60-69. PubMed ID: 36346503
[TBL] [Abstract][Full Text] [Related]
5. A method for tumor dosimetry based on hybrid planar-SPECT/CT images and semiautomatic segmentation.
Roth D; Gustafsson J; Sundlöv A; Sjögreen Gleisner K
Med Phys; 2018 Nov; 45(11):5004-5018. PubMed ID: 30199102
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in a Triple-Negative Breast Cancer Patient.
Besemer AE; Grudzinski JJ; Weichert JP; Hall LT; Bednarz BP
Cancer Biother Radiopharm; 2019 Feb; 34(1):13-23. PubMed ID: 30351218
[TBL] [Abstract][Full Text] [Related]
7. Is a single late SPECT/CT based kidney
Beykan S; Tran-Gia J; Borup Jensen S; Lassmann M
Phys Med; 2022 Aug; 100():39-50. PubMed ID: 35724608
[TBL] [Abstract][Full Text] [Related]
8. Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios.
Kupitz D; Wetz C; Wissel H; Wedel F; Apostolova I; Wallbaum T; Ricke J; Amthauer H; Grosser OS
PLoS One; 2017; 12(11):e0187570. PubMed ID: 29107992
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
10. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
Med Phys; 2016 Oct; 43(10):5279. PubMed ID: 27782699
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of single-photon emission computed tomography/computed tomography in post-ablation
Jiang L; Xiang Y; Huang R; Tian R; Liu B
Pediatr Radiol; 2021 Aug; 51(9):1724-1731. PubMed ID: 33759024
[TBL] [Abstract][Full Text] [Related]
12. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
[TBL] [Abstract][Full Text] [Related]
13. Investigation of post-therapeutic image-based thyroid dosimetry using quantitative SPECT/CT, iodine biokinetics, and the MIRD's voxel S values in Graves' disease.
Fujita N; Koshiba Y; Abe S; Kato K
EJNMMI Phys; 2020 Jan; 7(1):6. PubMed ID: 31993828
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
An YS; Park DY; Min BH; Lee SJ; Yoon JK
BMC Med Imaging; 2021 Mar; 21(1):60. PubMed ID: 33771130
[TBL] [Abstract][Full Text] [Related]
15. Validation of Monte Carlo
Adam DP; Grudzinski JJ; Bormett I; Cox BL; Marsh IR; Bradshaw TJ; Harari PM; Bednarz BP
Med Phys; 2022 Aug; 49(8):5491-5503. PubMed ID: 35607296
[TBL] [Abstract][Full Text] [Related]
16. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
[TBL] [Abstract][Full Text] [Related]
17. OEDIPE: a personalized dosimetric tool associating voxel-based models with MCNPX.
Chiavassa S; Bardiès M; Guiraud-Vitaux F; Bruel D; Jourdain JR; Franck D; Aubineau-Lanièce I
Cancer Biother Radiopharm; 2005 Jun; 20(3):325-32. PubMed ID: 15989479
[TBL] [Abstract][Full Text] [Related]
18. Activity quantification combining conjugate-view planar scintigraphies and SPECT/CT data for patient-specific 3-D dosimetry in radionuclide therapy.
Berker Y; Goedicke A; Kemerink GJ; Aach T; Schweizer B
Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2173-85. PubMed ID: 21901383
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
[TBL] [Abstract][Full Text] [Related]
20. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
